Kelly Steven has filed 22 insider transactions across 2 companies since March 2023.
Most recent transaction: a grant/award of 292 shares of ARTELO BIOSCIENCES, INC. ($ARTL) on January 30, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Not found | A | Stock Options (right to buy) | 292 | $0.00 | 292.0000 | 1,555,493 | 9999.99% | 0.02% |
| Jan. 28, 2025 | Carisma Therapeutics Inc. | $CARM | Kelly Steven | President and CEO | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 20, 2024 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Not found | A | Stock Option (right to buy) | 1750 | $0.00 | 1,750.0000 | 3,188,959 | 9999.99% | 0.05% |
| June 17, 2024 | Carisma Therapeutics Inc. | $CARM | Kelly Steven | President and CEO | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2024 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Director | D | Stock Option (right to buy) | 9634 | $0.00 | 0.0000 | 3,188,959 | 100.00% | 0.30% |
| Feb. 28, 2024 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Director | D | Stock Option (right to buy) | 667 | $0.00 | 0.0000 | 3,188,959 | 100.00% | 0.02% |
| Feb. 28, 2024 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Director | D | Stock Option (right to buy) | 667 | $0.00 | 0.0000 | 3,188,959 | 100.00% | 0.02% |
| Feb. 28, 2024 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Director | D | Stock Option (right to buy) | 667 | $0.00 | 0.0000 | 3,188,959 | 100.00% | 0.02% |
| Feb. 28, 2024 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Director | D | Stock Option (right to buy) | 1083 | $0.00 | 0.0000 | 3,188,959 | 100.00% | 0.03% |
| Feb. 28, 2024 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Director | A | Stock Option (right to buy) | 1484 | $0.00 | 1,484.0000 | 3,188,959 | 9999.99% | 0.05% |
| Feb. 28, 2024 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Director | A | Stock Option (right to buy) | 9634 | $0.00 | 9,634.0000 | 3,188,959 | 9999.99% | 0.30% |
| Feb. 28, 2024 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Director | A | Stock Option (right to buy) | 667 | $0.00 | 667.0000 | 3,188,959 | 9999.99% | 0.02% |
| Feb. 28, 2024 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Director | A | Stock Option (right to buy) | 667 | $0.00 | 667.0000 | 3,188,959 | 9999.99% | 0.02% |
| Feb. 28, 2024 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Director | A | Stock Option (right to buy) | 1083 | $0.00 | 1,083.0000 | 3,188,959 | 9999.99% | 0.03% |
| Feb. 28, 2024 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Director | A | Stock Option (right to buy) | 667 | $0.00 | 667.0000 | 3,188,959 | 9999.99% | 0.02% |
| Feb. 28, 2024 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Director | D | Stock Option (right to buy) | 1484 | $0.00 | 0.0000 | 3,188,959 | 100.00% | 0.05% |
| Jan. 31, 2024 | Carisma Therapeutics Inc. | $CARM | Kelly Steven | President and CEO | A | Stock Option (Right to Buy) | 438000 | $0.00 | 438,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 4, 2023 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Not found | A | Stock Option (right to buy) | 1083 | $0.00 | 1,083.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | ARTELO BIOSCIENCES, INC. | $ARTL | Kelly Steven | Not found | A | Stock Option (right to buy) | 667 | $0.00 | 667.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Carisma Therapeutics Inc. | $CARM | Kelly Steven | President and CEO | A | Stock Option (Right to Buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Carisma Therapeutics Inc. | $CARM | Kelly Steven | President and CEO | A | Stock Option (Right to Buy) | 625797 | $0.00 | 625,797.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2023 | Carisma Therapeutics Inc. | $CARM | Kelly Steven | President and CEO | A | Stock Option (Right to Buy) | 415968 | $0.00 | 415,968.0000 | 0 | 9999.99% | 0.00% |